We report the case of a 61-year-old patient with a history of prostate cancer affected by bone metastasis. He presented to our attention for ulcerous and necrotic cutaneous lesions unresponsive to antibiotics. The spread of cutaneous lesions and the onset of neurological symptoms suggested a cryptococcal disease, which was confirmed by lumbar puncture and cutaneous biopsy. We present the diagnostic and therapeutic approach to this case.
Cryptococcosis is an invasive fungal infection due to Cryptococcus neoformans or Cryptococcus gattii; the former is the principal pathogenic member of the genus and has a worldwide distribution .
Cryptococcosis is typical of immunocompromised patients, and among them historically HIV-positive patients, but there are some reports of presumed immunocompetent patients [2,3].
This disease can affect different organs: meningoencephalitis is the most described manifestation followed by pulmonary and cutaneous disease. The clinical presentation is heterogeneous, ranging from a mild disease to a life-threatening condition. It often presents with a subacute course with a delayed diagnosis, especially if a patient has various comorbidities.
A 61-year-old male patient affected by stage IV prostate cancer with bone metastasis at diagnosis presented to our Wound Care Clinic complaining of ulcers on the right forearm that appeared two weeks prior following a referred domestic trauma.
During the physical examination, we observed two ulcers on the right forearm: a 6 cm x 4 cm proximal posterior ulcer covered by fibrin and a 2-cm proximal anterior ulcer with odorous exudate. There was no presence of crackles on palpation of the area surrounding the ulcers. Following a cutaneous swab, which resulted positive for unspecified yeast, the patient was admitted to our clinic.
Besides the aforementioned cancer disease, the patient’s medical history included hypertension, cholelithiasis, colon-sigma diverticulosis, and a recent discharge from another hospital for sepsis, bladder rupture, and multifocal pneumonia without microbiological evidence, which were treated successfully with piperacillin/tazobactam.
The patient’s pharmacological therapy consisted of bicalutamide, high-dose dexamethasone (4 mg a day for more than three months), oxycodone/naloxone, pregabalin, celecoxib, zoledronate, irbesartan, amlodipine, bisoprolol, proton pump inhibitors, and delorazepam.
CT scan of the right forearm revealed an extended inflammation of the dermis and hypodermis and excluded any abscesses or signs of necrotizing fasciitis (Figure 1). Blood tests revealed the presence of moderate inflammation with a CRP (C-reactive protein) of 24 mg/L WBC (white blood cell) count of 18.13 x 109/L, creatinine of 0.56 mg/dL, and ALT (alanine aminotransferase) of 52 U/L.
At the time of admission, the patient was afebrile. For the cutaneous lesion, empiric therapy was started with piperacillin/tazobactam 4.5 g every eight hours along with advanced dressings determined by the wound care physician.
In the following days, we observed an extended loss of organic substance (Figure 2A) with a progressive expansion of the ulcers (Figures 2B, 2C) despite the surgical curettage performed by the plastic surgeon and the advanced dressings performed by the wound care physician.
NNegative-pressure wound therapy was started without success, and the cultured foam samples isolated methicillin-resistant Staphylococcus aureus (Panton-Valentine negative). Therefore, we initiated vancomycin 1 g every 12 hours plus meropenem 1 g every 8 hours followed by a course of daptomycin 600 mg every 24 hours for the isolation of vancomycin-resistant Enterococcus in the rectal swab.
Despite the aforementioned therapy, the cutaneous lesion did not improve but instead advanced. Two new cutaneous lesions manifested on the right hand and left thigh. Both were red and non-tender papules and very similar to the initial presentation as reported by the patient prior to admission (Figure 2B). Subsequently, echocardiography excluded infectious endocarditis (Video 1) and an MRI of the right arm excluded osteomyelitis (Figure 3). To note, during hospitalization, blood tests showed only a minimal increase in the inflammation markers.
In the following days, the patient complained of frequent episodes of confusion and tremor associated with an increasing headache. CT of the brain was negative, electroencephalogram showed a diffuse pattern of encephalopathic suffering, and the neurological examination performed by a specialist showed metabolic encephalopathy.
Due to the association between the failure of broad-spectrum antibiotics and the onset of neurological symptoms, especially headache, we performed a lumbar puncture (Table 1) that isolated Cryptococcus neoformans. The cryptococcal antigen on serum was positive, and a cutaneous biopsy of the ulcers confirmed the presence of the yeast. Therefore, we started induction antifungal therapy with amphotericin B plus flucytosine and switched to consolidation therapy with fluconazole 400 mg following a repeat of the lumbar puncture (Table 1) after 16 days.
The immunological studies showed a profound cellular and humoral immunosuppression: CD4+ count of 0.123 x 103/mL, CD8+ count of 134 x 103/mL, CD4/CD8 count of 0.91, IgG of 4.18 g/L (normal range: 7.00-16.00), IgA of 0.79 g/L (normal range: 0.70-4.00), and IgM of 0.41 g/L (normal range: 0.40-2.30). The HIV test was negative.
We observed a rapid improvement of the neurological signs and the healing of the lesion on the left thigh, which had not yet ulcerated. The ulcers on the right arm gradually improved and the patient was transferred to another hospital in order to undergo a skin filling with collagen and then a plastic surgery (Figure 4) with an autologous skin graft (Figure 5). The surgery was successful and the patient was then switched to a maintenance therapy with fluconazole 200 mg from October 2019.
At the beginning of April 2020, during the terrible outbreak of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the patient, who lived in Lombardy, where the largest epidemic outbreak has developed in Italy, died after a respiratory failure. He presented no signs and symptoms of recrudescence of cutaneous and neurological cryptococcosis, but the cryptococcal antigen was still positive.
Up until now, most of the information we have regarding cryptococcosis is based on experience from HIV-positive patients. However, in recent years, thanks to the introduction of an effective antiretroviral therapy, HIV-positive patients have constituted an ever-smaller percentage of the total cases of cryptococcosis [3,4].
In a U.S. cohort study of 302 patients diagnosed with cryptococcosis, 108 (36%) were HIV-positive, 84 (28%) were transplant patients, and 110 (36%) were NHNT (non-HIV, non-transplant patients) . NHNT patients constitute a heterogeneous group that includes patients ranging from seemingly healthy to heavily immunodepressed [5,6].
Specific studies on this patient population are yet to be conducted due to both the high variability of the patients and their relatively recent increase in number. Recent studies have shown how the clinical presentation and mortality of this group of patients is different from that of HIV-positive patients, to whom most clinicians are accustomed . In fact, these patients most frequently present with extra-meningeal manifestations, of which the most frequent is pulmonary; cases of skin, osteoarticular, and soft tissue infections have been reported. In a recent study of 158 NHNT patients, 14 (9%) had infections other than pulmonary, bloodstream, or central nervous system. These included cultures from skin (n = 4), urine (n = 2), joint aspirates (n =2), ascites (n = 2), lymph node biopsy (n = 2), bone biopsy (n = 1), and ocular fluid (n = 1) .
There is no typical cutaneous lesion of cryptococcosis, but skin involvement is typically characterized by various non-specific presentations (e.g., papules, pustules, nodules, abscesses, edema, panniculitis, and ulcers) and can be due to a primary infection or due to a secondary systemic hematogenous spread [8-10]. Therefore, once a diagnosis is established, the infection of the brain and lungs must be excluded .
Our patient presented with two large and necrotic ulcers on his right forearm and was treated with broad-spectrum antibiotics. The initial cutaneous swabs detected an unspecified yeast, which was interpreted as a contamination. The association between the failure of different antibiotics and the onset of neurological symptoms suggested a form of encephalitis; therefore, we performed lumbar puncture in order to exclude an opportunistic infection.
The studies cited above and the clinical course of our patient showed that cutaneous symptoms in an immunocompromised patient should always alert about the possibility of an opportunistic infection such as cryptococcosis. The failure of a broad-spectrum course of antibiotics and the onset of neurological signs can be further differentials in the diagnosis.
Furthermore, the immunological studies, such as peripheral blood lymphocyte typing and immunoglobulin tests, could be useful to inform clinical management and suspect an opportunist infection, even in immunosuppressed non-HIV patients.
The domestic trauma, the extensive interval between the onset of the lesions and the first neurological sign (the headache was first noted 50 days following admission), and the isolation of an unspecified yeast on the first skin swab would lead us to think that the port of entry of the infection was the skin. However, the scarce data that are present in the literature and the typically subacute course of a cryptococcal meningeal infection often lead a patient to overlook these neurological symptoms, especially if the patient has multiple co-morbidities. Even if this case is suggestive of the skin being the primary infected organ, we cannot directly assume this.
An important teaching we learnt from this case is the necessity of direct communication and case discussion between the clinician and the microbiologist in the lab for a more careful and thorough interpretation of contaminations versus true infections in the patient sample. This is particularly important if there is a high clinical suspicion of an opportunistic infection.
The clinical case presented required a considerable expenditure of resources and energy. In fact, in search of a diagnosis, the hospitalization lasted several weeks consisting of the almost daily treatment with advanced dressings as well as the treatment of complications that arose during his stay. In addition, the follow-up was costly due to a long and difficult rehabilitation. The sudden death of this patient from respiratory failure during the coronavirus epidemic has been a further event in the recent weeks showing us the disparity between medical efforts and clinical results, causing us to put into question our work as healthcare professionals.
- Microbiology and epidemiology of Cryptococcus neoformans infection. (2020). Accessed: May 23, 2020: https://www.uptodate.com/contents/microbiology-and-epidemiology-of-cryptococcus-neoformans-infection/print?search=cry....
- Mitchell TG, Perfect JR: Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995, 8:515-548.
- Pappas PG, Perfect JR, Cloud GA, et al.: Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001, 33:690-699. 10.1086/322597
- Brizendine KD, Baddley JW, Pappas PG: Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. PLoS One. 2013, 8:e60431. 10.1371/journal.pone.0060431
- Swan CD, Gottlieb T: Cryptococcus neoformans empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature. BMJ Case Rep. 2018, 2018:bcr2018224786. 10.1136/bcr-2018-224786
- Pappas PG: Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc. 2013, 124:61-79.
- Hevey MA, George IA, Raval K, Powderly WG, Spec A: Presentation and mortality of cryptococcal infection varies by predisposing illness: a retrospective cohort study. Am J Med. 2019, 132:977-983. 10.1016/j.amjmed.2019.04.026
- Akram SM, Koirala J: Cutaneous cryptococcus (cryptococcosis). StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2019.
- Longhitano S, Peccerillo F, Odorici G, Bigi L, Pellacani G: An unusual presentation of primary cutaneous cryptococcosis. Dermatol Ther. 2019, 32:e12942. 10.1111/dth.12942
- Yokose M, Harada Y, Shimizu T: Behind the leg: cryptococcal meningitis, not cellulitis. Am J Med. 2020, 133:81-82. 10.1016/j.amjmed.2019.06.015
- Araki K, Yoshida y, Kohno h, Sugiyama e: A large deep skin ulcer as an initial manifestation of systemic cryptococcosis. Mycopathologia. 2019, 184:341-343. 10.1007/s11046-019-00322-1
Disseminated Cryptococcosis in a Patient With Metastatic Prostate Cancer Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
The authors would first like to thank the patient and his family who showed us a human way to fight against the disease. This made us find the time and energy to share this clinical case even in this difficult moment for Lombardy due to the COVID-19 outbreak. We would also like to thank all the medical staff, including nurses and paramedics, who tried to be allies of the patient in this impossible fight day-by-day.
Cite this article as:
Passerini M, Terzi R, Piscaglia M, et al. (May 23, 2020) Disseminated Cryptococcosis in a Patient With Metastatic Prostate Cancer Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak. Cureus 12(5): e8254. doi:10.7759/cureus.8254
Received by Cureus: April 29, 2020
Peer review began: May 05, 2020
Peer review concluded: May 16, 2020
Published: May 23, 2020
© Copyright 2020
Passerini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.